chr4-73077511-AG-A

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_032217.5(ANKRD17):​c.7430delC​(p.Pro2477LeufsTer7) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)

Consequence

ANKRD17
NM_032217.5 frameshift

Scores

Not classified

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 3.38

Publications

0 publications found
Variant links:
Genes affected
ANKRD17 (HGNC:23575): (ankyrin repeat domain 17) The protein encoded by this gene belongs to the family of ankyrin repeat-containing proteins, and contains two distinct arrays of ankyrin repeats in its amino-terminal region, one with 15 ankyrin repeats, and the other with 10 ankyrin repeats. It also contains a nuclear export signal, nuclear localization signal, and a cyclin-binding RXL motif. Localization of this protein to the nucleus has been shown experimentally, and interactions between this protein and cyclin-dependent kinase 2 have been observed. It has been suggested that this protein plays a role in both DNA replication and in both anti-viral and anti-bacterial innate immune pathways. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
ANKRD17 Gene-Disease associations (from GenCC):
  • syndromic complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Chopra-Amiel-Gordon syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-73077511-AG-A is Pathogenic according to our data. Variant chr4-73077511-AG-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 3600515.Status of the report is criteria_provided_single_submitter, 1 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032217.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANKRD17
NM_032217.5
MANE Select
c.7430delCp.Pro2477LeufsTer7
frameshift
Exon 32 of 34NP_115593.3
ANKRD17
NM_015574.2
c.7427delCp.Pro2476LeufsTer7
frameshift
Exon 32 of 34NP_056389.1O75179-2
ANKRD17
NM_001286771.3
c.7091delCp.Pro2364LeufsTer7
frameshift
Exon 32 of 34NP_001273700.1O75179-7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANKRD17
ENST00000358602.9
TSL:5 MANE Select
c.7430delCp.Pro2477LeufsTer7
frameshift
Exon 32 of 34ENSP00000351416.4O75179-1
ANKRD17
ENST00000509867.6
TSL:1
c.7091delCp.Pro2364LeufsTer7
frameshift
Exon 32 of 34ENSP00000427151.2O75179-7
ANKRD17
ENST00000558247.5
TSL:1
c.7079delCp.Pro2360fs
frameshift
Exon 32 of 34ENSP00000453434.1H0YM23

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions as Germline
Significance:Likely pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Chopra-Amiel-Gordon syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr4-73943228; API